Johanna Abend

Johanna Abend has significant work experience in the pharmaceutical industry. Johanna is currently working as the Senior Director of Virology at Via Nova Therapeutics since November 2021. Prior to that, they worked at BioMarin Pharmaceutical Inc. as a Senior Scientist in Immunogenicity Assessment from January 2019 to October 2021.

Their earlier experience includes working at the Novartis Institutes for BioMedical Research (NIBR) where they held multiple roles. Johanna started as an Investigator II in September 2011 and progressed to become a Senior Investigator I, leading cross-functional teams in anti-viral drug discovery and biologics. During their time at NIBR, they were involved in various project activities from high-throughput screening to IND filing and first-in-human studies. Johanna also served as a direct supervisor for a team of up to six research associates.

Before joining NIBR, Johanna worked as a Postdoctoral Fellow at the National Cancer Institute from May 2009 to September 2011.

Overall, Johanna Abend's work experience showcases their expertise in virology, immunogenicity assessment, and anti-viral drug discovery.

Johanna Abend obtained their Bachelor of Science (BS) degree in Microbiology and Immunology from the University of Rochester, where they studied from 1999 to 2003. Following this, they pursued a Doctor of Philosophy (Ph.D.) in Microbiology and Immunology at the University of Michigan, a course of study they completed from 2003 to 2008.